Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Advanced Solid Neoplasm × Rifampin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 3 Lymphoma, Non-Hodgkin 3 Lymphoma 3 Hematologic Neoplasms 2 Solid Tumor 1 Sarcoma, Synovial 1 Sarcoma 1 Rhabdoid Tumor 1 Multiple Myeloma 1 Mesothelioma 1 Melanoma 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Carcinoma, Non-Small-Cell Lung 1 Advanced Solid Tumors 1 Advanced Solid Neoplasm 1

Interventions

pevonedistat 2 Paclitaxel 2 Docetaxel 2 Carboplatin 2 Rifampin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03486314 2022-04-18

A Study to Evaluate the Effects of Rifampin on Pharmacokinetics (PK) of Pevonedistat in Participants With Advanced Solid Tumors

Takeda

Phase 1 Completed

20 enrolled 18 charts

Advanced Solid Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon ⚡